1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
DOWN'S SYNDROME AND ORAL CONTRACEPTIVE USAGE
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1976.tb00898.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 83, Issue 8, pages 617–620, August 1976
Additional Information
How to Cite
Janerich, D. T., Flink, E. M. and Keogh, M. D. (1976), DOWN'S SYNDROME AND ORAL CONTRACEPTIVE USAGE. BJOG: An International Journal of Obstetrics & Gynaecology, 83: 617–620. doi: 10.1111/j.1471-0528.1976.tb00898.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Abstract
- References
- Cited By
Summary
We examined the history of oral contraceptive usage in a group of 103 mothers of infants with Down's syndrome and an equal number of matched normal controls. We found no evidence of increased pill use among mothers of the abnormal infants either during the pregnancy or in the year before pregnancy.